Baby KJ's doctors plan to ask the FDA this winter to approve a clinical trial for a pioneering gene editing approach.
The proposed clinical trial would be open to patients with seven different urea cycle disorders, offering new hope for treatment.
“This is what we thought we would never get,”
Kyle Muldoon, Baby KJ's father, expressed his emotions as he shared a moment with his son while watching a football game.
Autor's resume: Baby KJ's medical team seeks FDA approval for gene editing trial.